Boule Diagnostics
ISIN: SE0011231158 | Ticker: BOUL | LEI: 213800IK1TGY858TKZ45
Country: Sweden
Boule Diagnostics develops and manufactures diagnostic instruments and consumables for healthcare providers worldwide. The company’s primary focus is in small to medium-sized hospitals, clinics, and laboratories in both human and veterinary diagnostics.
Boule has a strong heritage when it comes to hematology diagnostics. Our blood tests help provide one of the first and most important indicators of a disease state and Boule systems play an increasingly role in helping build the infrastructure of healthcare for small and medium size patient care environments in both human and veterinary diagnostic markets.
Boule operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through more than 200 distributors and partners in more than 100 countries, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011.
Worldwide
HeadquartersDomnarvsgatan 4, 16353 Spånga – Sweden
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 479,710,000.00 | 572,030,000.00 | 759,964,000.00 |
| Noncurrent Assets | N/A | 283,091,000.00 | 329,655,000.00 | 421,550,000.00 |
| Property Plant And Equipment | N/A | 54,745,000.00 | 47,426,000.00 | 58,574,000.00 |
| Machinery | N/A | 4,682,000.00 | 6,137,000.00 | 7,372,000.00 |
| Other Property Plant And Equipment | N/A | 10,985,000.00 | 11,230,000.00 | 12,350,000.00 |
| Goodwill | N/A | 72,906,000.00 | 78,693,000.00 | 88,123,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 115,625,000.00 | 162,885,000.00 | 225,235,000.00 |
| Noncurrent Trade Receivables | N/A | 36,816,000.00 | 36,822,000.00 | 45,796,000.00 |
| Other Noncurrent Financial Assets | N/A | 2,998,000.00 | 3,828,000.00 | 3,823,000.00 |
| Other Noncurrent Assets | N/A | 4,192,000.00 | 3,211,000.00 | 2,116,000.00 |
| Current Assets | N/A | 196,619,000.00 | 242,375,000.00 | 338,414,000.00 |
| Inventories | N/A | 54,542,000.00 | 59,038,000.00 | 75,265,000.00 |
| Current Raw Materials And Current Production Supplies | N/A | 35,803,000.00 | 30,431,000.00 | 31,372,000.00 |
| Work In Progress | N/A | 3,932,000.00 | 4,458,000.00 | 6,697,000.00 |
| Finished Goods | N/A | 14,807,000.00 | 24,149,000.00 | 37,196,000.00 |
| Trade And Other Current Receivables | N/A | 109,088,000.00 | 145,155,000.00 | 166,245,000.00 |
| Current Prepaid Expenses | N/A | 8,897,000.00 | 5,508,000.00 | N/A |
| Other Current Receivables | N/A | 3,517,000.00 | 7,764,000.00 | 4,869,000.00 |
| Current Tax Assets Current | N/A | 3,040,000.00 | 3,999,000.00 | 7,195,000.00 |
| Cash and cash equivalents | 21,580,000.00 | 32,989,000.00 | 38,183,000.00 | 96,904,000.00 |
| Equity And Liabilities | N/A | 479,710,000.00 | 572,030,000.00 | 759,964,000.00 |
| Equity | 332,870,000.00 | 269,305,000.00 | 295,735,000.00 | 462,504,000.00 |
| Issued Capital | N/A | 4,854,000.00 | 4,854,000.00 | 9,708,000.00 |
| Retained Earnings | N/A | 58,914,000.00 | 71,507,000.00 | 73,556,000.00 |
| Additional Paidin Capital | N/A | 202,403,000.00 | 202,386,000.00 | 336,763,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 269,305,000.00 | 295,735,000.00 | 462,504,000.00 |
| Liabilities | N/A | 210,405,000.00 | 276,295,000.00 | 297,459,000.00 |
| Noncurrent Liabilities | N/A | 57,672,000.00 | 65,094,000.00 | 96,426,000.00 |
| Deferred Tax Liabilities | N/A | 12,754,000.00 | 10,504,000.00 | 8,394,000.00 |
| Current Liabilities | N/A | 152,733,000.00 | 211,202,000.00 | 201,034,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 29,352,000.00 | 41,165,000.00 | 33,321,000.00 |
| Current Accruals And Current Deferred Income Including Current Contract Liabilities | N/A | N/A | 36,357,000.00 | 37,084,000.00 |
| Other Current Payables | N/A | 6,473,000.00 | 20,764,000.00 | 16,426,000.00 |
| Current Tax Liabilities Current | N/A | 3,304,000.00 | 6,662,000.00 | 7,635,000.00 |
| Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 400,458,000.00 | 463,344,000.00 | 548,087,000.00 |
| Profit Loss From Operating Activities | -5,928,000.00 | 36,018,000.00 | 28,970,000.00 |
| Gains Losses On Net Monetary Position | N/A | -3,109,000.00 | 5,000.00 |
| Finance Income | 1,522,000.00 | 1,352,000.00 | 1,778,000.00 |
| Finance Costs | 4,338,000.00 | 5,493,000.00 | 9,904,000.00 |
| Other Income Expense From Subsidiaries Jointly Controlled Entities And Associates | -40,278,000.00 | N/A | N/A |
| Profit Loss Before Tax | -49,021,000.00 | 28,768,000.00 | 20,849,000.00 |
| Income Tax Expense Continuing Operations | -1,056,000.00 | 5,496,000.00 | 8,121,000.00 |
| Profit (loss) | -47,966,000.00 | 23,272,000.00 | 12,728,000.00 |
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | -47,966,000.00 | 23,272,000.00 | 12,728,000.00 |
| Adjustments For Reconcile Profit Loss | N/A | 52,914,000.00 | 19,451,000.00 | 23,067,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -1,405,000.00 | -3,046,000.00 | -9,779,000.00 |
| Adjustments For Reconcile Profit Loss | N/A | 52,914,000.00 | 19,451,000.00 | 23,067,000.00 |
| Cash Flows From Used In Operations | N/A | 38,494,000.00 | 46,658,000.00 | 28,760,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 4,338,000.00 | 5,493,000.00 | 9,851,000.00 |
| Interest Received Classified As Operating Activities | N/A | 436,000.00 | 1,352,000.00 | 1,778,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 75,239,000.00 | 43,284,000.00 | -11,353,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 4,585,000.00 | 3,149,000.00 | 6,433,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -46,006,000.00 | -56,370,000.00 | -74,961,000.00 |
| Proceeds From Issuing Shares | N/A | N/A | N/A | 149,507,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 11,024,000.00 | 19,052,000.00 | 24,031,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 11,138,000.00 | 11,766,000.00 | 13,708,000.00 |
| Cash Flows From Used In Financing Activities | N/A | -14,881,000.00 | 15,754,000.00 | 140,550,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 14,351,000.00 | 2,669,000.00 | 54,236,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -2,942,000.00 | 2,525,000.00 | 4,486,000.00 |
| Cash and cash equivalents | 21,580,000.00 | 32,989,000.00 | 38,183,000.00 | 96,904,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 15.05.23 | Torben Jörgensen | Other | Buy | SEK 54,000.00 |
| 03.05.23 | Torben Jörgensen | Other | Buy | SEK 120,000.00 |
| 03.04.23 | Torben Jörgensen | Other | Buy | SEK 60,000.00 |
| 27.02.23 | Jan Benjaminson | Other | Buy | SEK 102,000.00 |
| 03.02.23 | Yvonne Mårtensson | Other | Buy | SEK 100,224.45 |
| 16.12.22 | Jesper Söderqvist | Other | Buy | SEK 34,680.10 |
| 15.12.22 | Jesper Söderqvist | Other | Buy | SEK 706,086.22 |
| 14.12.22 | Jesper Söderqvist | Other | Buy | SEK 223,533.84 |
| 21.11.22 | Emil Hjalmarsson | Other | Buy | SEK 105,200.00 |
| 29.12.21 | Jan Mattias Isaksson | Other | Buy | SEK 12,200.00 |
SE0011231158
LEI213800IK1TGY858TKZ45
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.